Results 111 to 120 of about 2,480 (127)

Therapeutic applications of AS1411 aptamer, an update review

International Journal of Biological Macromolecules, 2020
Rezvan Yazdian–Robati, Fatemeh Oroojalian, Mehryar Zargari   +2 more
exaly  

The Effect of AS1411 Surface Density on The Tumor Targeting Properties of Pegylated Silver Nanotriangles

Nanomedicine, 2022
Huiquan Yang, Dongdong Li, Fan Li
exaly  

G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms

Biochimica Et Biophysica Acta - General Subjects, 2017
Elsa M Reyes-Reyes, Mohammad Tariq Malik, Martin G O'Toole   +2 more
exaly  

Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer

Nuclear Medicine and Biology, 2014
Junling Li, Tariq Malik, John O Trent
exaly  

Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411

Cancer Investigation, 2018
Vivek R Sharma, Shelia D Thomas, Donald M Miller   +2 more
exaly  

Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers

International Journal of Biological Macromolecules, 2018
Claudia Riccardi, Domenica Musumeci, Irène Russo Krauss   +2 more
exaly  

Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411

Experimental Eye Research, 2020
OSCAR Vivanco-Rojas, BEATRIZ Buentello-Volante, Paula Bates   +2 more
exaly  

AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin

Nanomedicine: Nanotechnology, Biology, and Medicine, 2019
Mounira Chalabi-Dchar, Hichem C Mertani, Bernard Verrier   +2 more
exaly  

Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells

Journal of Drug Targeting, 2015
Zohreh Noaparast, Seyed Jalāl Hosseinimehr, Majid Piramoon   +2 more
exaly